Search

So what exactly are you looking for? Let us know and we will help you find the best answer

Explore Mutual Funds

Sytematic filtering of mutual funds across asset classes and criterias to suit your investment needs.

Explore Now
Clear All

Indraprastha Medical Corporation Ltd.

  • NSE: INDRAMEDCO

  • BSE: 532150

  • Q
  • V
  • T
  • Strong Performer
87.53/100

Quality Score

High Financial Strength
62.67/100

Valuation Score

Affordable Valuation
64.42/100

Technical Score

Technically Moderately Bullish
Broker average target upside %

587.60 %

Market Leader

TTM PE Ratio

9.70

Below industry Median

Price to Book Ratio

2.20

Below industry Median

Operating Revenues Qtr Cr

274.00 Cr

Above industry Median

Net Profit Qtr Cr

19.80 Cr

Above industry Median

RSI

70.60

RSI Overbought

MFI

75.60

MFI Overbought

MACD

1.60

MACD above Signal and Center

MACD Signal Line

1.00

MACD above Signal and Center

30Day SMA Rs

85.30 Rs

Price above SMA 85.26

50Day SMA Rs

83.30 Rs

Price above SMA 83.34

100Day SMA Rs

83.30 Rs

Price above SMA 83.33

200Day SMA Rs

78.70 Rs

Price above SMA 78.73

Promoter holding %

51.00

No change in Promoter holding

FII holding current Qtr %

0.27

FII holdings fell by 0.50%

MF holding current Qtr %

0.00

MF holding at 0.00%

Institutions holding %

0.27

Institutions holding decreased by 0.5000%.

Broker Average Rating

5.00

Broker Average Rating

Broker Covering stock

1.00

1 Broker Covering stock

Broker 1Year total

1.00

1 Broker 1Year total

Broker 6M Reco downgrade

0.00

0 Broker 6M Reco downgrade

Broker 6M Reco upgrade

0.00

0 Broker 6M Reco upgrade

Broker 6M Target downgrade

0.00

0 Broker 6M Target downgrade

Broker 6M Target upgrade

0.00

0 Broker 6M Target upgrade

Momentum score

64.42

Technically Moderately Bullish

Valuation score

62.67

Affordable Valuation

Quality score

87.53

High Financial Strength

NSE INDRAMEDCO
90.90
  • 89.25 Close
  • 89.25 Open
  • 1.96 Lk Volume
Today Low/High
Low 89.00
High 92.00
52 Week Low/High
Low 52.05
High 94.30
    • 2023-05-24T08:00:18+00:00

    INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Pursuant to Regulation 30 read with Schedule III (Part A) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit copies of the public notice of the financial results, published on 24th May, 2023, in the 'Financial Express', all India editions, in English language and in 'Jansatta', Delhi edition, in Hindi language.

    Read More
    • 2023-05-23T11:57:10+00:00

    INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Related Party Transactions For The Half Year Ended 31St March, 2023

    Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit disclosure of Related Party Transactions for the half year ended 31st March, 2023.

    Read More
    • 2023-05-23T11:48:17+00:00

    INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Results For The Financial Year Ended 31St March, 2023 And Recommendation Of Dividend

    This is to inform that the Board of Directors of the Company has, at its meeting held on Tuesday, 23rd May, 2023 (i.e. today), inter-alia : 1. Approved the Audited Financial Statements for the year ended 31st March, 2023 and Audited Financial Results for the quarter/year ended 31st March, 2023, as recommended by the Audit Committee; and 2. Recommended a dividend @ 30% i.e. Rs. 3.00 per share for the financial year 2022-23. The meeting of the Board of Directors commenced at 3.00 p.m. and concluded at 5:00 p.m. We shall inform you in due course of time, the date on which the Company will hold its Annual General Meeting for the year ended 31st March, 2023, and the date from which dividend, if approved by the shareholders, will be paid or warrants thereof dispatched to the shareholders.

    Read More
    • 2023-05-23T11:43:05+00:00

    INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 23Rd May, 2023

    This is to inform that the Board of Directors of the Company has, at its meeting held on Tuesday, 23rd May, 2023 (i.e. today), inter-alia : 1. Approved the Audited Financial Statements for the year ended 31st March, 2023 and Audited Financial Results for the quarter/year ended 31st March, 2023, as recommended by the Audit Committee; and 2. Recommended a dividend @ 30% i.e. Rs. 3.00 per share for the financial year 2022-23. Pursuant to regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, The meeting of the Board of Directors commenced at 3.00 p.m. and concluded at 5:00 p.m. We shall inform you in due course of time, the date on which the Company will hold its Annual General Meeting for the year ended 31st March, 2023, and the date from which dividend, if approved by the shareholders, will be paid or warrants thereof dispatched to the shareholders.

    Read More
    • 2023-05-16T07:52:55+00:00

    INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg.24(A)-Annual Secretarial Compliance

    Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit Annual Secretarial Compliance Report from a practicing Company Secretary, for the year ended 31st March, 2023. This is for your information and record.

    Read More
    • 2023-05-12T11:42:26+00:00

    INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Pursuant to Regulation 30 read with Schedule III (Part A) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit copies of the public notice of the date of the Board meeting, published on 12th May, 2023, in the 'Financial Express', all India editions, in English language and in 'Jansatta', Delhi edition, in Hindi language. You are requested to take the above information on record.

    Read More
    • 2023-05-11T07:51:59+00:00

    INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Intimation for Board Meeting To Consider And Approve Audited Financial Results And Dividend, If Any, For The Financial Year 2022-23

    INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Tuesday, 23rd May, 2023, inter alia: - a) to consider and approve the audited financial results for the quarter/ year ended 31st March, 2023; and b) to consider and recommend dividend, if any, on equity shares of the Company for the financial year 2022-23.

    Read More
    • 2023-04-26T11:46:00+00:00

    INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyINDRAPRASTHA MEDICAL CORP.LTD. 2CIN NO.L24232DL1988PLC030958 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY AA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ICRA LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: PRIYA RANJAN Designation: AVP CORPORATE AFFAIRS LEGAL EmailId: priya_r@apollohospitalsdelhi.com Name of the Chief Financial Officer: C P TYAGI Designation: CHIEF FINANCIAL OFFICER EmailId: tyagi@apollohospitalsdelhi.com Date: 26/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

    Read More
    • 2023-04-15T08:03:51+00:00

    INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Credit Rating

    Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that ICRA Limited has given long term credit ratings at [ICRA]AA (pronounced ICRA Double A) for Rs. 62.50 crore bank facilities and short term credit ratings at [ICRA]A1+ (pronounced ICRA A One Plus) for Rs. 40.0 crore Commercial Paper to the Company.

    Read More
    • 2023-04-15T08:01:39+00:00

    INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliance Certificate Under Regulation 40(10)

    Pursuant to Regulation 40(10) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find a copy of the certificate from a practicing Company Secretary certifying that all certificates have been issued, for the financial year ended 31st March, 2023, within 30 days of the date of lodgment for

    Read More
    • 2023-04-13T10:41:35+00:00

    INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliance Certificate For The Period Ended 31St March, 2023

    Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find the compliance certificate for the period 1st April, 2022 to 31st March, 2023.

    Read More
    • 2023-04-13T10:38:23+00:00

    INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    In compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, enclosed please find herewith a Certificate dated 5th April, 2023, issued by M/s. Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company, for the quarter ended 31st March, 2023.

    Read More
    • 2023-03-23T09:24:30+00:00

    INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Closure of Trading Window

    Pursuant to the provisions of the Code of Conduct for Prevention of Insider Trading, under SEBI (Prohibition of Insider Trading) Regulations, 2015, it is hereby informed that Trading Window for dealing in shares of the Company, will remain closed with effect from 1st April, 2023 till 48 hours after the declaration of audited financial results for the quarter / year ending 31st March, 2023. The date of the Board Meeting to consider the audited financial results for the quarter / financial year ending 31st March, 2023, shall be intimated separately.

    Read More
    • 2023-03-21T06:13:07+00:00

    INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    This is to inform you that the Company has issued duplicate share certificate in respect of Share Certificates reported to be lost by the shareholders. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificates are as given below: Name of the Shareholder Folio no. No. of shares Old Certificate Nos. Distinctive Nos. New Certificate No. Rajni Chawla Jt. Satpal Chawla 21868 100 179486 77114501-77114600 209865 Manoj Kr. Jain 12014 600 93767 - 93772 77530201-77530800 209864 This is for your information and record.

    Read More
    • 2023-02-13T11:44:36+00:00

    INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    This is to inform you that the Company has received intimation from the shareholders on 11th February, 2023, regarding loss of share certificates. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificates are as given below: Name of the Shareholder Folio no. No. of shares Certificate Nos. Distinctive Nos. Rajni Chawla Jt. Satpal Chawla 21868 100 179486 77114501-77114600 Manoj Kr. Jain 12014 600 93767 - 93772 77530201-77530800 This is for your information and record.

    Read More
    • 2023-02-08T12:14:56+00:00

    INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December, 2022

    This is to inform that the Board of Directors of the Company has, at its meeting held on Wednesday, 8th February, 2023 (i.e. today), inter-alia, considered and approved the Un-audited Financial Results for the quarter and nine months ended 31st December, 2022, along with the Limited Review Report of the statutory auditor. We are enclosing herewith the Un-audited Financial Results for the quarter and nine months ended 31st December, 2022, along with a copy of the Limited Review Report by the Statutory Auditors of the Company. The Board meeting commenced at 3.00 p.m. and ended at 5.30 p.m.

    Read More
    • 2023-02-08T12:10:39+00:00

    INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 8Th February, 2023

    This is to inform that the Board of Directors of the Company has, at its meeting held on Wednesday, 8th February, 2023 (i.e. today), inter-alia, considered and approved the Un-audited Financial Results for the quarter and nine months ended 31st December, 2022, along with the Limited Review Report of the statutory auditor. We are enclosing herewith the Un-audited Financial Results for the quarter and nine months ended 31st December, 2022, along with a copy of the Limited Review Report by the Statutory Auditors of the Company. The Board meeting commenced at 3.00 p.m. and ended at 5.30 p.m.

    Read More
    • 2023-01-23T07:36:13+00:00

    INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Intimation for Consider And Approve Unaudited Financial Results For The Quarter And Nine Months Ended 31St December, 2022

    INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Wednesday, 8th February, 2023, to consider and approve, the unaudited financial results for the quarter and nine months ended 31st December, 2022.

    Read More
    • 2023-01-14T05:29:00+00:00

    INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    In compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, enclosed please find herewith a Certificate dated 5th January, 2023, issued by M/s. Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company, for the quarter ended 31st December, 2022. This is for your information and record.

    Read More
    • 2022-12-24T07:27:46+00:00

    INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Closure of Trading Window

    Pursuant to the provisions of the Code of Conduct for Prevention of Insider Trading, under SEBI (Prohibition of Insider Trading) Regulations, 2015, it is hereby informed that Trading Window for dealing in shares of the Company, will remain closed with effect from 1st January, 2023 till 48 hours after the declaration of un-audited financial results for the quarter and nine months ending 31st December, 2022. The date of the Board Meeting to consider the un-audited financial results for the quarter and nine months ending 31st December, 2022, shall be intimated separately.

    Read More

Ex-date Dividend Amount Dividend Type Record Date

Bonus History

Adani Ports & Special Economic Zone Ltd. has not announced any bonus since Jan 1, 2000.

Check out stocks with top dividend

Adani Ports & Special Economic Zone Ltd. has split the face value 1 time since Sept. 23, 2010. Adani Ports & Special Economic Zone Ltd. had last split the face value of its shares from Rs 10 to Rs 2 in 2016.The share has been quoting on an ex-split basis from Sept. 23, 2010.

Ex-date Old FV New FV Record Date
Sept. 23, 2010 10 FINAL Sept. 24, 2010

Tradebulls Securities is one of the leading Indian financial corporations aimed to make trading easier for everyone, even for those who are from a non-trading background. Being in the market for over 11 years, Tradebulls has earned its huge clientele of 2 Lakh+ clients, 2750+ business partners till date. Starting from a small firm with the overwhelming responses and trust from our customers, today we have expanded our operations to 18+ branches in the top cities of India including Mumbai, Bengaluru, Delhi, Ahmedabad, Kolkata, Gandhinagar, Surat, Rajkot, Vadodara. If you are new in the ‘trading business’, you should definitely know about the unique products that we offer to our customers like ‘Target’; to analyse future profit prospects, ‘Portfolio Optimizer’; to select the best portfolio depending upon the required outcome, ‘Investmentz Buckets’; to determine the sensitivity of a portfolio, ‘DIY Screeners’; program to filter stocks as per customer’s requirements. Also, other information related to Equity and Derivatives, Commodity Derivatives, Currency Derivatives, Online Share Trading, IPO, Mutual funds, Demat account, Trading account and Intraday trading are available on our website for you to gain familiarity with. Tradebulls is here for you with its professionally trained team to offer knowledge and guide you through the same.

Keeping some of the common issues faced by traders in mind, Tradebulls introduced a couple of popular online series; ‘Market bloopers’ and ‘Learning series’, which are available on YouTube, Facebook, Instagram, Twitter and LinkedIn. The purpose behind creating these 2 series is to disrupt the myths about ‘trading’ and teach about ‘how to trade’ respectively.

If you are thinking of entering the ‘the world of Share Market or Stock Market’, but do not know where to begin from, reach out to us on the below provided contact details or visit us personally at any of our branches.